Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

TARGETING THE NONCANONICAL NF-κB PATHWAY REVERSES SIV LATENCY

By Enthusiast Inc MDMarch 5, 2019

…longitudinally and levels of cell-associated SIV-RNA and -DNA were quantified in resting CD4+ T-cells isolated from peripheral blood, lymph nodes (LN), spleen and bone marrow (BM). We performed flow cytometric…

706 – Development of a 2-Drug Long-Acting Removable Formulation for HIV Suppression

By Jimmy He PharmD, DScMarch 20, 2025

…better outcomes and treatment continuation. Here, an in situ forming implant system (ISFI) was used to develop a long-acting (LA) formulation that can co-deliver two drugs post-administration of a single formulation….

877 – European HIV-1 A6 International Transmission Networks Are Enriched by Migrating Populations

By Jimmy He PharmD, DScMarch 31, 2026

…transmission dynamics in the region. Here we aimed to provide insight on the international A6 transmission patters across selected European regions including enrichment related to migration. Methods We assembled all…

Linkage of Rare Drug Resistance Mutations Detected by New Ultrasensitive SGS

By Enthusiast Inc MDFebruary 16, 2016

…of variants in plasma samples. NGS uSGS libraries were generated by tagging cDNA molecules from plasma RNA with primer IDs, optimizing PCR, and generating overhangs on amplicons for efficient ligation…

Functional Brain Network Changes Among People With HIV and Viral Suppression

By Jimmy He PharmD, DScMarch 6, 2024

…Methods: A total of 56 participants (69.6% VS-PWH; 51.7% female, 69.6% black) completed the MRI session and performed a battery of cognitive tests using the iPad-based platform Brain-Baseline Assessment of…

CXCR5 EXPRESSION ON HUMAN CD8+ T CELLS IS TIGHTLY REGULATED BY EPIGENETIC MECHANISMS

By Jimmy He PharmD, DScApril 28, 2020

…We FACS-sorted CXCR5+CD8+ (fCD8s), CXCR5–CD8+ (non-fCD8s), naïve CD8+ T cells and GCTfh from lymph nodes of HIV-1 infected individuals and performed RNA-sequencing (RNA-Seq). DNA methylation was used to profile methylation pattern of the CXCR5…

MULTI-CENTER PROSPECTIVE VALIDATION STUDY OF A NOVEL ANTIGEN ASSAY FOR TALAROMYCOSIS

By Jimmy He PharmD, DScMarch 3, 2023

…standard of culture-confirmed talaromycosis from any specimen over the 6-month follow-up period, the Mp1p EIA has a preliminary sensitivity of 84.5% (60/71, 95% CI: 73.5-91.4), specificity of 94.9% (337/355, 95%…

B-Cells Augment HIV-1 Expression in Secondary Lymphoid Tissues

By Jimmy He PharmD, DScMarch 6, 2024

…CD3+CD8- cells and GFP median fluorescence intensity (MFI) determined by flow cytometry. Tonsil cells were also sorted into CD4+ T follicular helper (TFH; CD3+CD8-CXCR5hiPD-1hi), nonTFH (CD3+CD8-CXCR5+/-PD-1+/-), memory B (IgD-CD38-), pre-germinal…

530 – AZD5582 Inhibits Vaccine-Elicited CD8+ T-Cell Responses in SIV-Infected Rhesus Macaques on ART

By Jimmy He PharmD, DScMarch 20, 2025

…a mean of 18.1 ± 6% in group C and 25.0 ± 4.4% in group A (p=0.35) (Figure 1A). However, at week 15, after 5 doses of AZD5582, responses sharply declined to a mean of 0.2 ±…

Steady State and Post-Vaccination TFH Dynamics in HIV Patients Treated With cART

By Enthusiast Inc MDFebruary 16, 2016

HIV infection dramatically changes the lymph node (LN) tissue architecture and the dynamics of tissue resident immune cells, potentially affecting the ability of HIV infected individuals to respond to subsequent…

←1
2345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576
…7778798081…
82
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top